- $7.10bn
- $8.46bn
- $2.88bn
Arcosa Inc reports results for the quarter ended in March - Earnings Summary
Arcosa Inc expected to post earnings of 51 cents a share - Earnings Preview
Brief: Arcosa, Inc. Announces $750 Million Of Additional Wind Tower Orders And Plans For New Facility In New Mexico
U.S. RESEARCH ROUNDUP-Fubotv, Opal Fuels, Revolution Medicines
U.S. RESEARCH ROUNDUP-Block, C4 Therapeutics, Westlake
Arcosa Inc reports results for the quarter ended in December - Earnings Summary
Brief: Arcosa, Inc. Announces Fourth Quarter And Full Year 2022 Results
Brief: Arcosa Announces Fourth Quarter and Full Year 2022 Results
Arcosa Inc expected to post earnings of 21 cents a share - Earnings Preview
Brief: Arcosa Inc Declares Quarterly Dividend And Renews $50 Million Share Repurchase Authorization
U.S. RESEARCH ROUNDUP-Linkbancorp, Oyster Point Pharma, Viatris
Arcosa Inc reports results for the quarter ended in September - Earnings Summary
Brief: Arcosa Announces Third Quarter 2022 Results
Arcosa Inc expected to post earnings of 62cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Carvana, McKesson, Nektar Therapeutics
U.S. RESEARCH ROUNDUP-Enovix, IRhythm Technologies, Paramount Global
Brief: Arcosa, Inc. Announces Second Quarter 2022 Results
Hedge fund Ides ask Monro to pressure shareholder preventing company sale
Arcosa Inc reports results for the quarter ended in March - Earnings Summary